# Taizhou Taifa Pharmaceuticals Co., Ltd. – FDA Inspection, May 15, 2019

Source: https://www.keypedia.com/records/fda_inspections/taizhou-taifa-pharmaceuticals-co-ltd/36b71010-c8c3-4145-b1ac-4570c589c2a9
Source feed: FDA_Inspections

> FDA inspection 1094254 of Taizhou Taifa Pharmaceuticals Co., Ltd., May 15, 2019. Classification: Official Action Indicated (OAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094254
- Company Name: Taizhou Taifa Pharmaceuticals Co., Ltd.
- Inspection Date: 2019-05-15
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 990107 - 2016-09-15
- FDA Inspection 883252 - 2014-05-15
- FDA Inspection 676458 - 2010-08-05

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/laurimer-kuilan-torres/a7f49e33-9d35-4dfe-8bcc-d369d3834ef4)

Company: https://www.keypedia.com/companies/taizhou-taifa-pharmaceuticals-co-ltd/ffb9eee9-0ca2-4c62-a2ec-bb973a5cc18c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c